Afrin Rafiq

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Indian Institute of Technology Bombay(Current)

National Cancer Institute

Homi Bhabha National Institute

Afrin Rafiq is an author at Indian Institute of Technology Bombay specializing in refractory acute lymphoblastic leukemia, relapsed acute lymphoblastic leukemia, and oncology.

ORCID

Publications per year

2021–2025

Publications

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells

Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh et al. · Molecular Cancer Therapeutics · 2021 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17

Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study

Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain et al. · Blood Cancer Journal · 2025 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2